More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$248.08B
EPS
18.96
P/E ratio
35.4
Price to sales
5.25
Dividend yield
0.281%
Beta
0.843248
Previous close
$688.75
Today's open
$689.72
Day's range
$667.94 - $692
52 week range
$435.27 - $727.56
show more
CEO
Marc N. Casper
Employees
125000
Headquarters
Waltham, MA
Exchange
New York Stock Exchange
Shares outstanding
370515868
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Thermo Fisher (TMO) Up 1.8% Since Last Earnings Report: Can It Continue?
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Nov 20, 2026

Thermo Fisher Scientific Sees Faster 2027 Growth as Biotech Spending Recovers
Thermo Fisher Scientific NYSE: TMO expects growth to strengthen in 2027 as biotechnology spending improves and academic research activity stabilizes, Chairman and CEO Marc Casper said during a UBS CEO Call Series discussion.
MarketBeat • Nov 19, 2026

Thermo Fisher Scientific Inc. (TMO) Presents at UBS 2026 CEO Call Series Transcript
Thermo Fisher Scientific Inc. (TMO) Presents at UBS 2026 CEO Call Series Transcript
Seeking Alpha • Nov 19, 2026

Thermo Fisher Scientific Launches Gibco™ VaxEvo™ CD 293 Medium to Advance Adenovirus Vaccine Production
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ VaxEvo™ CD 293 Medium, a chemically defined and animal origin-free medium designed to support suspension HEK293 cell growth and high-titer adenovirus production. Available in liquid and AGT™ formats, the medium is designed to support vaccine developers from early process development through scale-up and manufacturing. As suspension-based HEK293 workflows evolve to support s.
Business Wire • Nov 18, 2026

Worried investors are paying up for these stocks — some with up to 49% upside, analysts say
Defensive sectors have beaten the S&P 500 by a wide margin in recent months, even though they are priced much higher relative to earnings estimates than the index.
Market Watch • Nov 18, 2026

Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will participate in a fireside chat hosted by UBS on Thursday, November 19th, at 8:30 a.m. (ET). The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, wi.
Business Wire • Nov 13, 2026

Thermo Fisher Scientific Continues Semiconductor Lab-to-Fab Innovation with Multiple Installations of Optis™ FIB-SEM
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has completed multiple installations of the Thermo Scientific Optis™ focused ion beam-scanning electron microscope (FIB-SEM). As semiconductor manufacturers develop increasingly complex chips that power everything from smart devices to healthcare technologies, they need faster, more accurate and consistent data to drive innovation. The system combines automated sample pre.
Business Wire • Nov 10, 2026

Should You Continue to Hold TMO Stock in Your Portfolio?
Thermo Fisher's accelerating organic growth, rising bioproduction demand and strong capital returns support its outlook, but macroeconomic risks and competition remain concerns.
Zacks Investment Research • Nov 9, 2026

Thermo Fisher Scientific Authorizes $5 Billion Share Buyback after Upbeat Earnings
Thermo Fisher Scientific, Inc. (NYSE:TMO) shares are trading higher by about half a percent on Friday as the company authorized a new share repurchase program and risk appetite is firm, with S&P 500 futures up 1.2%.
Benzinga • Nov 6, 2026

Diamond Hill Large Cap Fund Q3 2026 Portfolio Update
The Fund returned 3.18% compared to a 2.61% return for the Russell 1000 Value Index. Key contributors include Microsoft, Salesforce and Thermo Fisher Scientific. Key detractors include Aon, Carrier Global and Builders FirstSource.
Seeking Alpha • Nov 6, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Thermo Fisher Scientific Inc commission-free¹. Build wealth for the long term using automated trading and transfers.